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Background: The global prevalence and incidence of renal calculi is reported to be increasing. Of the patients that
undergo surgical intervention, nearly half experience symptomatic complications associated with stone fragments
that are not passed and require follow-up surgical intervention. In a clinical simulation using a clinical prototype,
ultrasonic propulsion was proven effective at repositioning kidney stones in pigs. The use of ultrasound to
reposition smaller stones or stone fragments to a location that facilitates spontaneous clearance could therefore
improve stone-free rates. The goal of this study was to determine an injury threshold under which stones could be
safely repositioned.
Methods: Kidneys of 28 domestic swine were treated with exposures that ranged in duty cycle from 0%–100% and
spatial peak pulse average intensities up to 30 kW/cm2 for a total duration of 10 min. The kidneys were processed
for morphological analysis and evaluated for injury by experts blinded to the exposure conditions.
Results: At a duty cycle of 3.3%, a spatial peak intensity threshold of 16,620 W/cm2 was needed before a
statistically significant portion of the samples showed injury. This is nearly seven times the 2,400-W/cm2 maximum
output of the clinical prototype used to move the stones effectively in pigs.
Conclusions: The data obtained from this study show that exposure of kidneys to ultrasonic propulsion for
displacing renal calculi is well below the threshold for tissue injury.
Keywords: Injury threshold, Kidney stones, Ultrasonic propulsionBackground
The clinical uses of ultrasound (US) span both diagnos-
tic and therapeutic applications. This broad range of ap-
plications is due to the variety of bioeffects that can be
elicited in tissue with US. The potential for tissue dam-
age resulting from US has resulted in a need for safety
guidelines to be established. Although guidance on the
safety of diagnostic US was initiated in the 1970s, early
discussions focused only on thermal bioeffects. It was
not until the late 1980s that the safety of non-thermal
mechanics was considered [1,2]. Despite the decades of
research on the bioeffects of US, safety guidelines for
therapeutic US have yet to be established [3], and treat-
ment levels that lie between traditional diagnostic and* Correspondence: ynwang@u.washington.edu
1Center for Industrial and Medical Ultrasound, Applied Physics Laboratory,
University of Washington, 1013 NE 40th Street, Seattle, WA 98105, USA
Full list of author information is available at the end of the article
© 2014 Wang et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the ortherapeutic ultrasound categories have not been fully
addressed. With the emergence of new applications util-
izing a wide range of US systems, including diagnostic/
therapeutic hybrids such as the Verasonics system (Redmond,
WA, USA) [4], patient safety needs to be carefully evalu-
ated for these in-between exposures. One such new appli-
cation involves using US to expel renal calculi [5-7].
The global prevalence and incidence of renal calculi is
reported to be increasing [8], with the recent National
Health and Nutrition Examination Survey (NHANES)
reporting a prevalence of 1 in 11 in the USA [9]. Shock-
wave lithotripsy (SWL) remains the principal treatment
of symptomatic renal calculi (National Kidney Founda-
tion) despite the tissue damage that can occur as a result
[10-12]. Stone fragments are often left after SWL, which
can act as nuclei for the formation of new stones, result-
ing in the need for further intervention or retreatment.td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.





Sensitivity to duty cycle at maximum
prototype intensity
3.3% Duty cycle 100% Duty cycle ISPPA.3 = 9,320 W/cm
2
ISPPA.3 (W/cm
2) Samples ISPPA.3 (W/cm
2) Samples Duty cycle (%) Samples
0 29 0 13 0 13
930 12 470 3 2 7
2,530 14 930 6 6 5
4,090 10 2,530 7 10 8
6,030 10 4,090 8 25 3
9,320 12 6,030 5 50 5




Exposures were based on the expected clinical exposure parameters (3.3% duty cycle), maximum duty cycle (100%) of clinical device, and for a range of duty
cycles at an intensity with similar peak positive and negative pressures as the clinical device. The samples represent the number of tissue samples evaluated for
injury at each condition.
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to use ultrasound to reposition kidney stones [5-7,13,14].
Application includes expelling not only residual frag-
ments from the kidney but also de novo stones, accessing
stones during surgery, and dislodging large emergent
obstructing stones [14]. Pulses with maximum inten-
sity of 2,400 W/cm2 have been used to reposition
stones in animals effectively [5] and without observed
injury [5,13].
The goal of this study was to evaluate acoustic inten-
sities below which the ultrasonic propulsion system may
be safely operated to reposition kidney stones. A custom
research device was used to treat surgically exposed kid-
neys over a wide range of intensities. A threshold for in-
jury was established by applying the plateau statistical
model to the tissue evaluation. The results were compared
to conventional lithotripsy output intensities and the out-
put intensities used in a clinical simulation of treatment
on a porcine model [5]. The results are not an exhaustive
parameterization of safe outputs but an investigation
of safety issues relevant to the outputs used in stoneFigure 1 Schematic of the treatment bursts. The 3.3% duty cycle consis
10-min treatment duration.relocation, which may have relevance to other ultrasound
applications as well as future clinical development.
Methods
Ultrasound device
These studies used a custom-built experimental ultra-
sound system [6,15]. In brief, the device consists of a 6-cm
diameter, 2-MHz, eight-element annular array curved
to fit a natural focus of 6 cm (H-106, Sonic Concepts,
Bothell, WA, USA). An SC-200 radiofrequency synthe-
sizer (Sonic Concepts, Bothell) provides eight channels
of phase-delayed signals that are amplified by individ-
ual custom-modified 100-W IC-706MIKIIG amplifiers
(Icom®, Bellevue, WA, USA) to excite the eight ele-
ments of the array. The focal depth of the treatment
could be adjusted from 3.5 to 9.5 cm by using software
written in MATLAB® (Mathworks, Waltham, MA,
USA) to control the relative phase delay of each elem-
ent. The focus was maintained between 1 and 1.5 cm
below the kidney surface, which corresponds to a 6 or
6.5 cm total depth. Treatments were guided with ats of a 100 μs long burst of pulses repeated every 3 ms over the
Figure 2 Typical waveforms produced by the research device. Measurements were performed in water showing the maximum achievable
(solid line), minimum (dotted line), and a waveform approximating the peak positive and negative pressures generated by the clinical prototype
(dashed line).
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5000 Ultrasound system (Philips Ultrasound, Bothell, WA,
USA). The transducer surface was kept cool by circulating
water set to 8°C through the coupling cone using a modi-
fied water chilling system (EW-12108-10, Cole-Parmer®,
Vernon Hills, IL, USA). The treatments were guided with
a coaxially aligned P4-2 imaging transducer and an HDI-
5000 ultrasound system (Philips Ultrasound).Treatment exposures
The research device was used to deliver a wide range of
ultrasound doses (Table 1). Three different treatment
protocols were implemented; all protocols had a total
treatment time of 10 min. B-mode ultrasound imaging
occurred throughout all exposures, but only the therapy
exposures are discussed. The first protocol tested a 3.3%
duty cycle burst consisting of a 100-μs long pulse re-
peated every 3 ms (Figure 1). This exposure protocol
was identical to that used for the clinical simulation
study [5]. The second protocol tested a 100% duty cycle
(constant burst) output for 10 min (no time off ). This
protocol was intended to mimic a maximum dose treat-
ment, in which the device was used in continuousTable 2 Grading criteria for histological evaluation of
the kidneys
Score Description
0 No treatment associated lesions
1 Focal degenerative change including epithelial
cell swelling, tissue hyperemia (congestion)
2 Degenerative change accompanied by focal
regions of individual epithelial cell necrosis
3 Focal coagulative or liquefactive necrosis
(emulsification) with hemorrhage
Samples with scores of 1 and above were considered to be injured.operation. For the third protocol, one intensity was
chosen and the duty cycle was varied by adjusting the
length of the US burst while maintaining a 3-ms pulse
period. The intensity was 10,700 W/cm2 in water, dera-
ted to 9,320 W/cm2 at a depth of 1 cm into the kidney
tissue. This treatment mode evaluated the injury sensi-
tivity to duty cycle at the maximum un-derated pressure
of the clinical prototype, that is, assuming the ultra-
sound was focused into the kidney without attenuation
from overlying tissues.
The intensity values in Table 1 and in this paper repre-
sent the spatial peak pulse average. The intensities were
derated based upon the methods developed for non-
linear high-intensity focused ultrasound (HIFU) waves
[16-18] using a derating factor of 0.3 dB/cm/MHz,
which is recognized by the FDA [19,20]. The maximum
spatial peak pulse averaged intensity (ISPPA) that could
be achieved with the research device was found to be
30,000 W/cm2 in water with a corresponding peak posi-
tive pressure of 96 MPa and a peak negative pressure of
16 MPa (Figure 2). This corresponds to a derated ISPPA.3
of approximately 26,000 W/cm2 at 1-cm tissue depth.
The pressure waveforms showing the range of treatment
intensities measured in water are provided in Figure 2
for comparison.Animal treatment protocol
The kidneys of the domestic swine were treated in vivo
following a protocol approved by the Institutional Animal
Care and Use Committee at the University of Washington.
A total of 28 female pigs weighing 101–141 lbs were se-
dated with an intramuscular injection of telazol (4 mg/kg).
Anesthesia was maintained using isofluorane (1.5%–2.5%)
via endotracheal tube. The abdomen was opened, and
the intestines were repositioned to one side to reveal
the kidney that was to be treated. The overlying renal
Figure 3 Injury at 3.3% duty cycle. Proportion of samples that
show injury versus the spatial peak pulse averaged intensity. All
exposures were at 3.3%. Dashed line indicates threshold. Error bars
represent one standard deviation. When no error bars are observed,
all evaluations were in agreement.
Figure 4 Histological examples of injury. Most histologic changes in thi
congestion and varied only slightly from the control tissue (A). Modestly m
intensity and consisted of some focal congestion and hemorrhage along w
a single subcapsular site. Above the threshold, tissue injury was more pron
degenerative epithelial cells surrounded by areas of tubular epithelial cell n
were distinct foci (dashed line) of liquefactive necrosis or emulsification (E)
tissue and resulted in cavities which were filled with lysed and intact eryth
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with degassed phosphate buffered saline (PBS) for
coupling of the transducer. The kidney was immobi-
lized with wet gauze; care was taken to avoid placing
the gauze in the US path.
The US transducer was positioned, and the renal par-
enchyma was targeted for treatment. The transducer has
a water-filled cone that is 5 cm in length (as measured
from the center of the curved transducer). The cone was
placed directly on the kidney, and the transducer was
programmed to a focal depth of 6 or 6.5 cm. The focal
depth is programmable and controlled by the timing of
the different elements of the eight-element annular
array. This makes the focus 1–1.5 cm inside the kidney.
The settings (Table 1) used for each exposure were ran-
domly selected at each treatment spot. Up to seven dis-
tinct locations were treated in each kidney. The areas
were kept treatment free for control samples. With the
exception of the 100% duty cycle exposures, the USs study were subtle consisting of mild cell swelling or tissue
ore significant lesions infrequently occurred below the threshold
ith individual cell necrosis and tissue compression evident here (B) in
ounced. Large, focal pale region (dashed line, C) composed of
ecrosis with sloughing of tubular lining cells (D). At the extreme, there
that on higher magnification (F) abruptly interfaced with more normal
rocytes (hemorrhage).
Figure 5 Changes during the 3.3% duty cycle protocol.
Proportion of samples showing hyperechogenicity or gross changes
versus the derated spatial peak pulse averaged intensity. All
exposures were at 3.3%.
Figure 7 Hyperechoic region during treatment. Screen shot of a
hyperechoic region (yellow arrow) observed in the kidney tissue
during treatment (3.3% duty cycle; 26,130 W/cm2). Treatment
direction was from the top (Red arrow). Scale in centimeters.
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ance of echogenicity in the focal region. After each ex-
posure, the kidney was inspected, and the treatment
location was marked with histology ink. Any visible
gross changes to the kidney surface were also noted.
In order to maximize the in situ intensity exposure
and to accurately mark and analyze the treated tissue,
the kidneys were immobilized and exposed directly to
the US energy, rather than transcutaneously, as would
be the standard protocol in humans. The two ap-
proaches are equated by the focal derated acoustic inten-
sity. As noted in [13], output levels were insufficient toFigure 6 Gross surface change. Photo of a typical gross surface
change after treatment (3.3% duty cycle; 26,130 W/cm2). Arrow
indicates edge of surface reddening. The treatment direction was
into the page. Scale bar in millimeters.generate observable kidney injury with exposure through
the skin and the corresponding acoustic attenuation. All
the animals were euthanized upon completion of the ex-
perimental treatment.
Injury evaluation
The kidneys treated at a duty cycle of 3.3% were perfu-
sion fixed in situ before being removed for routine histo-
logical evaluation [21]. Individual treatment locations as
indicated by the histology ink and control tissues were
embedded separately in paraffin, and sections were
stained with hematoxylin and eosin (H&E) and periodic
acid-Schiff (PAS). This protocol is an established tissue
preparation technique used to analyze the hemorrhagic
lesion induced by SWL in pigs and also associated with
mechanical effects of low duty cycle pulses [21]. Stained
slides from the treated and control samples were ran-
domized and reviewed by three independent experiencedFigure 8 Injury at fixed duty cycle. Proportion of samples
showing injury with increasing derated spatial peak pulse averaged
intensity at a fixed duty cycle of 100%. Dashed red line represents
the threshold.
Figure 9 NADH-d evaluation. Example of full thickness (entire kidney) tissue section stained with NADH-d (top). Treatment location was from
the left (Red arrow). Non-treated parenchyma stains purple/blue (bottom left); lesion is identified by non-staining (black arrow and bottom right).
This tissue was treated at a duty cycle of 50% at a fixed derated spatial peak pulse averaged intensity of 9,320 W/cm2.
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viewer provided histopathological descriptions of each
slide. From these descriptions, the slides were scored ac-
cording to a grading rubric developed by a veterinary
pathologist (Table 2). The specimens that were given a
score of 1 or above were considered to be injured. The re-
sults were therefore binary in nature for statistical analysis.
The kidneys treated at a duty cycle of 100% and with a
constant intensity of 9,320 W/cm2 were removed and
immediately processed for preparation of frozen sec-
tions. The frozen sections were stained for nicotinamide
dinucleotide diaphorase (NADH-d) to evaluate thermal
injury [22]. Stained slides from the treated and controlFigure 10 Injury at a fixed intensity. Proportion of samples
showing injury with increasing duty cycle at a fixed derated spatial
peak pulse averaged intensity of 9,320 W/cm2.samples were randomized and reviewed by one experi-
enced expert blind to the experimental conditions. Only
one individual reviewed the NADH-d-stained slides as
the reading was binary; areas with non-stained tissue in-
dicated thermal damage and was marked as being posi-
tive for injury. This is an established preparation
technique for analysis of porcine renal and hepatic injury
from HIFU, which is associated with thermal effects for
high duty-cycles or long duration pulses [22,23]. Since
these studies used longer pulses more like HIFU than
SWL, NADH staining was chosen.
Statistics
For the 3.3% duty cycle data, inter-observer variability was
evaluated using an intra-class correlation (ICC) with a
95% confidence interval before averaging across observers.
The threshold for injury for all three sets of data (3.3%
duty cycle, 100% duty cycle, constant intensity) was calcu-
lated using the plateau model. The threshold for the echo-
genicity of the 3.3% duty cycle group was also determined
using a generalized plateau model since the outcomes
were binary. The plateau model is a special case of the lin-
ear change point model, where the second slope is zero,
which was tested and confirmed in analysis [24]. In the
plateau model, the dependent variable, denoted as y, is re-
lated to the independent variable, denoted as x, in two dif-
ferent ways. The change point x0 defines when the
relationship changes, which is referred as the threshold in
this paper. For x > x0, y is linearly related to x. For x < x0,
Table 3 Parameter comparison for the clinical prototype for displacing renal calculi, shockwave lithotripsy, and
diagnostic ultrasound
Device Fc (MHz) Pulse duration (μs) Duty cycle P
+ (MPa) P− (MPa) ISPPA.3 (W/cm
2)
Clinical lithotripter 0.5 5 0.001 for 60 min 37–115 −10 20,000
Diagnostic US 2 1 0.01–1 continuous 4 3 190
Clinical simulation 2 100 3.3% in 1 s bursts 20 −10 2,400
Injury threshold 2 100 3.3% for 10 min 96 −16 16,620
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plateau). In this paper, y is the tissue injury and x is the in-
tensity. For intensity below the threshold, there is basically
no tissue injury; when the intensity is above the threshold,
the injury increases with the intensity. Random intercepts
were used to account for within-subject correlations. The
threshold was selected by searching over candidate points,
and model selection was performed using Akaike informa-
tion criteria. Two-sided p < 0.05 were considered statisti-
cally significant. All analyses were performed using SAS
9.3 (SAS Institute, Cary, NC, USA).
Results
3.3% Duty cycle
The ICC between the reviewer scores was found to be
0.86 (95% 0.66–0.95), which means that the three re-
viewers were in near-perfect agreement. Consequently,
the averages of the three reviewer scores were used for
all subsequent analyses. Figure 3 shows a plot of the pro-
portion of samples that showed histological injury versus
the derated spatial peak pulse averaged intensity. The
plateau model revealed a change point (threshold) at a
derated intensity of 16,620 W/cm2, below which the
probability of injury was less than 0.2. Below the thresh-
old, histologic changes detected following this treatment
protocol were relatively minor, consisting of background
lesions, or focal tubular epithelial cell changes such as
cell swelling consistent with a mild degenerative change.
The vast majority of the samples were similar in appear-
ance to the control samples (Figure 4A). Of the 69 tissue
samples treated below the threshold (not including the
controls), only 2 samples displayed an evidence of focal
individual cell necrosis and/or hemorrhage. These le-
sions were typically superficial in nature (Figure 4B) and
were not found at the targeted focus position in the par-
enchyma. Neither lesion showed evidence of emulsifica-
tion (liquefactive necrosis). All other histological changes
detected below the threshold were relatively mild, typically
degenerative, and rarely involved individual cell necrosis.
Above the threshold intensity, the lesions contained focal
areas of emulsification, individual cell, and coagulative ne-
crosis, which were frequently accompanied by hemorrhage
(Figure 4C,D,E,F). Many of the lesions seen in the tissue
treated above the change point were on the order ofmillimeters and could sometimes be seen in gross obser-
vation of the surface.
Although the proportion of gross changes observed
immediately after treatment generally tracked with the
pattern for the histological observations (Figure 5), gross
surface changes did not necessarily correlate with histo-
logical injury, particularly below the threshold. Below
the 16,620-W/cm2 threshold, the proportion of samples
that showed gross changes was slightly higher than the
proportion of samples with histological signs of injury.
The majority of the gross changes observed included
reddening or congestion (Figure 6). In many cases, the
gross changes were not apparent after perfusion and on
tissue sections.
Hyperechogenic focal regions (Figure 7) were some-
times observed during treatment and usually appeared
immediately after the start of the exposure. The propor-
tion of treatments that exhibited focal hyperechogenicity
generally tracked with the occurrence of histological in-
jury (Figure 5). No hyperechogenic regions were ob-
served at or below an intensity of 4,090 W/cm2. Above
the histological injury threshold, the probability of ob-
serving a hyperechogenic region is greater than 0.5. Both
the curves for gross changes and for hyperechogencity
show (Figure 5) a rise in the proportion, showing hyper-
echogenicity or injury, respectively, to a level 0.5 or
higher above 16,000 W/cm2, which is consistent with
the threshold in Figure 3.100% Duty cycle
For the 100% duty cycle exposures, the plateau model
determined a change point at a derated spatial peak in-
tensity of 470 W/cm2 (Figure 8). Aside from the control
samples, no other intensities were evaluated below this
threshold with the NADH-d stain. Above this threshold,
the lesions observed were on the order of millimeters to
centimeters in size. Treated regions showed no evidence
of staining (Figure 9). A large rise in the proportion of
injury from 0.4 to 1 was observed at 6,000 W/cm2. At
higher intensities, the lesions often extended the whole
thickness of the kidney, and thermal lesions were visible
on both the anterior and posterior surfaces of the kidney
after treatment.
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At a fixed intensity of 9,320 W/cm2, the plateau model de-
termined a change point at a duty cycle of 2% (Figure 10).
At this level, the probability of injury is below 0.2. There is
another prominent rise in the curve at 50% duty cycle,
where the probability first exceeds 0.5 and rises to 1. The
probability of injury is rather low and insensitive to duty
cycle up to 25%. As in the 100% duty cycle section, injury
was identified with the NADH-d stain, which is shown
in Figure 9.Discussion
In this study, the exposure range to move kidney stones
by ultrasonic propulsion was expanded to explore
thresholds for tissue injury. A duty cycle of 3.3% was se-
lected specifically to compare with a clinical simulation
previously performed in pigs [5]. At a 3.3% duty cycle,
over a total of 10 min, the threshold for injury was found
at 16,620 W/cm2. In the clinical simulation, stones were
effectively moved using a 3.3% duty cycle, but with only
26 bursts of pulses that extended only for 1 s each and
derated spatial peak intensities near 2,400 W/cm2 (through
7 cm of tissue). This is the derated intensity delivered
transcutaneously to a depth of 7 cm. Thus, even this
threshold is conservative, and the calculated injury
threshold indicates that the intensity could be safely in-
creased if more force was needed to, for example, de-
tach a large stone from the tissue or to fragment a
stone without the fear of generating tissue injury.
Table 3 shows a comparison across acoustic exposures
for urolithiasis and the injury thresholds.
Above the threshold intensity at the 3.3% duty cycle,
the injury was found to range from individual cell nec-
rosis to frank emulsification of the tissue with focally
extensive hemorrhage. Only two samples below the
threshold displayed hemorrhaging, and these instances
of hemorrhage were at the surface of the kidney. It is
possible that these injuries were caused by poor trans-
ducer coupling, or tissue-handling trauma, which would
not occur in the clinical setting as treatment would be
performed transcutaneously. It is important to note that
both these cases occurred above 6,030 W/cm2, 2.5 times
the intensity used in the clinical simulation to move kid-
ney stones. Although both gross surface changes and
focal hyperechogenicity during the exposure tracked
with the histological injury patterns were observed, the
proportions were slightly higher than observed histologi-
cally, particularly close to the calculated histological
threshold. Again, it is possible that these events could
have been at the surface or in the coupling to the tissue
that would not be present in clinical use, but suggest
that both gross surface changes and focal hyperecho-
genicity may occur before histological injury is observed.When treatment was performed continuously for
10 min, the threshold for injury was found to be at
470 W/cm2. This low threshold could be due to the na-
ture of the plateau model used to calculate the change
point that identifies a single primary change point. It is
possible that another change point occurs between 4,090
and 6,030 W/cm2, as there is a large jump in the propor-
tion of samples, showing injury between these intensities
(double). On looking at the quality of tissue injury, the
second change point appears to be the true threshold for
injury, whereas the original arises from randomly low in-
jury in this control or lowest exposure data set. How-
ever, not enough information is available to evaluate
these differences statistically. The observation of a low
threshold for injury during continuous operation is a
clear indication that ultrasonic propulsion has the po-
tential to be injurious and that the system must be used
in brief bursts such as performed in our clinical simula-
tion [5]. Further, it is highly unlikely that this technology
could be inadvertently misused in this way, given that
continuous energy output would interfere with imaging
and would be observed early in the treatment. In
addition, many instruments designed to create pulses,
often by charging a capacitor, would not be capable of
producing a continuous sustained output.
This study suggests that duty cycles greater than 20%
at a spatial peak intensity of 9,320 W/cm2 would be
needed before the probability of injury rises above 0.3.
Although this intensity approximates the maximum that
could be achieved by an unmodified clinical prototype at
a 4-cm focus without attenuation from tissue, this inten-
sity is approximately four times greater than the in situ
intensity that was used to effectively move stones in pigs.
In all cases, 10 min at a steady duty cycle and focal loca-
tion is significantly more US bursts than would be used
clinically as the operator would need time between
bursts to reacquire the stone and reposition the trans-
ducer. In the clinical simulation, the average procedure
time was approximately 14 min, which corresponds to
an average delay time of 41 s between bursts [5,13].
The types of injury observed at high outputs are con-
sistent with those seen in SWL and other focused ultra-
sound therapies [13]. Overall, the results support earlier
reports that injury is not seen at the levels used to re-
position kidney stones [5,13]. There is room to adjust
the intensity, duty cycle, number of bursts, and exposure
duration without observing injury. As the peak pressure
of the clinical prototype is one half that commonly used
in SWL and the total energy delivered is less than one
fourth [5], these results are also consistent with those of
the previous reports with SWL outputs, where reduc-
tions of 10%–20% in peak pressure and 20%–50% in en-
ergy from standard lithotripsy eliminate measureable
anatomic injury [12].
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cess the kidneys for treatment by direct contact with the
US probe. For future clinical application, treatments will
be performed transcutaneously, as was the method used
in our clinical simulation [5]. In the current study, surgi-
cal access was chosen to ensure localization of the
treated site, fine control of the exposure levels, and opti-
mal utilization of the kidney tissue (up to seven lesions
could be created in one kidney). When performed on an
intact subject aberration of the beam, and more import-
antly, breathing motion, is likely to spread the acoustic
energy over a larger volume of tissue and thus reduce
the likelihood of injury. Future preclinical transcutane-
ous studies will need to address the potential of collat-
eral injury to adjacent tissues, but given the dose levels
proposed, this is highly unlikely.
Though the system in this study is different than the
prototype, there are enough similarities between the sys-
tems to see that the identified injury threshold is far
above the output levels capable of the prototype system.
The acoustic data presented here are for intensity only;
other parameters are reported elsewhere [5]. A limita-
tion of this presentation include the fact that intensity
does not account for non-linear acoustic effects, which
can affect heating, such that different pulse shapes with
a similar intensity can potentially cause different forms
of thermal injury. Still, for the purpose of evaluating
conditions relevant to propulsion of kidney stones, dis-
cussions in terms of intensity are appropriate.
Conclusion
This preclinical exploratory study helps establish the mar-
gins of safety associated with the use of focused ultra-
sound for renal calculi displacement. Consequential injury
only occurred with treatment conditions that far exceeded
the dose needed to displace stones from the kidney. These
settings are not even possible with the current clinical
prototype. Thus, ultrasound to reposition kidney stones
has the potential to be safe and effective.
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